Cassaday & Co Wealth Management’s Champions Oncology CSBR Stock Holding History
Bought
Maintained
Sold
Other funds holding CSBR
MBAM
Cassaday & Co Wealth Management's CSBR Position: Q3 2026 in Review
Cassaday & Co Wealth Management held its Champions Oncology (CSBR) position steady in Q3 2026 at 10 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #1241.
Cassaday & Co Wealth Management first reported a position in CSBR in Q1 2026 and has held it in 3 quarters since. The position peaked at $62 in Q2 2026. 26 funds tracked by Wall St. Rank hold CSBR as of Q3 2026.
- Cassaday & Co Wealth Management held 10 shares of Champions Oncology worth $50 as of Q3 2026.
- Cassaday & Co Wealth Management left its Champions Oncology share count unchanged in Q3 2026.
- Champions Oncology made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q3 2026, its #1241 holding.
- Cassaday & Co Wealth Management first reported a position in Champions Oncology in Q1 2026 and has held it in 3 quarters since.
- Cassaday & Co Wealth Management's Champions Oncology position peaked at $62 in Q2 2026.
- 26 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2026.
Based on Cassaday & Co Wealth Management's 13F filing for Q3 2026, filed 27 Oct 2026.